Biogena Group (BIO) Fair Value & Analysis
Consumer Defensive · AT · Market cap €12.2M
Fair value as of: Jun 24, 2026
From 13 valuation models · updated 5 days ago
Share price +19.6% over the past month.
Price vs Fair Value (12 months)
12‑month range €3.05 – €5.68 · fair‑value band €0.6300 – €1.04 · the €4.54 price screens above the €0.8400 fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Biogena Group (BIO) currently trades at €4.54, while our model-based Fair Value estimate is €0.8400 — implying the stock looks roughly 81.5% overvalued today. We read business quality at 89/100 (high quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
The stock trades on a trailing P/E of 43.7. Fundamentals as of Jun 24, 2026
Key figures & financial health
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
Biogena Group Invest AG engages in the provision of dietary supplements. The company is based in Salzburg, Austria.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Biogena Group reported revenue of €368K in FY2025 versus €329K in FY2021, a compound +2.8%/yr. Reported net income was €330K in FY2025, compounding +29.7%/yr from FY2021.
Open the full interactive analysis →
Similar stocks
6 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Nestlé S.A NSRGF | $97.58 | $65.41 | -33% |
| Foshan Haitian Flavouring and Food Company 603288 | ¥35.10 | ¥25.34 | -28% |
| Nestlé India Limited NESTLEIND | ₹1,386 | ₹278.10 | -80% |
| Grupo Bimbo, S.A. BIMBOA | 57.10 MXN | 45.03 MXN | -21% |
| Uni-President Enterprises Corp 1216 | 75.60 TWD | 55.53 TWD | -27% |
| Britannia Industries Limited BRITANNIA | ₹5,218 | ₹3,567 | -32% |
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is Biogena Group (BIO) undervalued?
What is the fair value of BIO?
What is the quality score of BIO?
What is the net profit margin of BIO?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.